gip vs glp 1 TrimRX Gastrointestinal Incretins—Glucose-Dependent Insulinotropic Polypeptide (GIP)

Evaluation of the effects of exenatide administration in patients with type 2 diabetes with worsened glycemic control caused by glucocorticoid therapy

You can read the abstract of this article at Triple-Hormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial PubMed (nih.gov)

h , Quantification of cFOS + cells in nucleus of the solitary tract (NTS)

In addition, effective June 1, 2026, Caremark will lift the new-to-market block on Foundayo (orforglipron), an oral GLP-1 therapy, for plans that approve coverage

This study, which included around 6,400 patients, employed Cox regression analysis and confirmed that diabetic patients using GLP-1R agonistssuch as exenatide, liraglutide, dulaglutide, and semaglutide were less likely to receive a new glaucoma diagnosis (80)

Theyre not just meant for diabetes